Amneal Pharmaceuticals, Inc.

AMRX · Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

Amneal Pharmaceuticals, Inc. (AMRX), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 6 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 13 and filed Aug 14. The most active filer was Gautam Patel with 7 filings.

Add to watchlist

Filings, ttm

0 buys · 6 sells

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$9.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 13

Filed Aug 14

ADViAverage daily dollar volume

$37.7M

market data

Share price · 12M

$17.73 (+77.3%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $70.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

GP Gautam Patel Director 7 filings NS Nikita Shah Executive Vice President 6 filings JD Jason B. Daly SVP, Chief Legal Officer 5 filings JK John Kiely Director 4 filings AB Andrew S Boyer Executive Vice President 3 filings DA Deborah M. Autor Director 2 filings TK Tasos Konidaris Executive Vice President & CFO 2 filings EA Emily Peterson Alva Director 1 filing

Recent filings

John KielySALE Director $882K
50,000 sh × $17.64
Exec Aug 13
Filed Aug 14 · 4:29 PM ET Nikita ShahSALE Executive Vice President $2.6M
146,403 sh × $17.51
Exec Aug 12
Filed Aug 13 · 4:22 PM ET Jason B. DalySALE EVP, Chief Legal Officer $3.8M
216,613 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 4:21 PM ET Deborah M. AutorSALE Director $451K
34,819 sh × $12.94
Exec May 11
Filed May 12 · 5:30 PM ET Ted C NarkSALE Director $586K
50,000 sh × $11.72
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET Nikita ShahSALE Executive Vice President $1.6M
131,856 sh × $11.92
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET John KielySALE Director $295K
32,000 sh × $9.23
Exec Aug 27 2025
Filed Aug 28 2025 · 5:30 PM ET Nikita ShahSALE Executive Vice President $1.1M
114,492 sh × $9.66
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET Andrew S BoyerSALE Executive Vice President $2.6M
279,244 sh × $9.38
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET Tasos KonidarisSALE Executive Vice President & CFO $4.7M
499,730 sh across 3 lots
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET Nikita ShahSALE Executive Vice President $666K
71,694 sh × $9.29
Exec Aug 14 2025
Filed Aug 15 2025 · 5:30 PM ET Andrew S BoyerSALE Executive Vice President $303K
33,436 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET Jason B. DalySALE EVP, Chief Legal Officer $199K
22,000 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET Nikita ShahSALE Executive Vice President $452K
50,000 sh × $9.04
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET Gautam PatelSALE Director $761K
94,906 sh × $8.02
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET Gautam PatelSALE Director $453K
56,426 sh × $8.02
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET Nikita ShahSALE Executive Vice President $372K
49,140 sh × $7.58
Exec May 16 2025
Filed May 19 2025 · 5:30 PM ET John KielySALE Director $380K
50,000 sh × $7.59
Exec May 12 2025
Filed May 13 2025 · 5:30 PM ET Gautam PatelSALE Director $664K
80,000 sh × $8.30
Exec Apr 1 2025
Filed Apr 2 2025 · 5:30 PM ET Tushar Bhikhubhai PatelSALE 10% owner $41.8M
5,000,000 sh × $8.35
Exec Mar 14 2025
Filed Mar 17 2025 · 5:30 PM ET Emily Peterson AlvaSALE Director $712K
80,000 sh × $8.90
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET Tasos KonidarisSALE Executive Vice President & CFO $891K
100,000 sh × $8.91
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET Jason B. DalySALE EVP, Chief Legal Officer $792K
90,000 sh across 2 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET Andrew S BoyerSALE Executive Vice President $1.1M
125,000 sh × $8.89
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET Gautam PatelSALE Director $712K
80,000 sh × $8.90
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET